Skip to main content

Advertisement

Log in

Chronic Pain and Mood Disorders Are Not Barriers to Symptom Improvement Under Collaborative Co-managed Care (C3)

  • Brief Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Objectives

Patients with comorbid chronic pain and mood disorders have more severe gastrointestinal disease and higher healthcare expenses than their peers. We sought to determine whether management under our innovative Collaborative Co-Managed Care (C3) general gastroenterology care model improved outcomes.

Methods

Patient questionnaires completed by outpatients at our GI Motility Center were analyzed alongside demographic information to determine predictors of response to treatment based on adequate relief of gastrointestinal symptoms and improvement in quality of life.

Results

These comorbidities did not significantly impair response and may be associated with improved response under our model.

Conclusions

The C3 general gastroenterology care model anchors on setting expectations and team-based communication and improves outcomes of, and access to, care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Yu V, Ballou S, Hassan R et al. Abdominal pain and depression, not bowel habits, predict health care utilization in patients with functional bowel disorders. Am J Gastroenterol. 2021;116:1720–1726.

    Article  PubMed  Google Scholar 

  2. Shah ED, Barry LA, Connolly ML et al. Collaborative Co-Managed Care (C3): a sustainable gastrointestinal motility practice model. Clin Gastroenterol Hepatol. 2022;20:1907–1911.

    Article  PubMed  Google Scholar 

  3. Moons KGM, Altman DG, Reitsma JB et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1-73.

    Article  PubMed  Google Scholar 

  4. Turnbull BW. Nonparametric estimation of a survivorship function with doubly censored data. J Am Stat Assoc. 1974;69:169–173.

    Article  Google Scholar 

  5. Finkelstein DM. A proportional hazards model for interval-censored failure time data. Biometrics. 1986;42:845.

    Article  CAS  PubMed  Google Scholar 

  6. Drossman DA, Chang L, Deutsch JK et al. A review of the evidence and recommendations on communication skills and the patient–provider relationship: a Rome foundation working team report. Gastroenterology. 2021;161:1670-1688.e7.

    Article  PubMed  Google Scholar 

Download references

Funding

Dr. Shah was supported by the AGA Research Foundation’s 2019 American Gastroenterological Association-Shire Research Scholar Award in Functional GI and Motility Disorders. Dr. Shah is supported by K23 DK134752.

Author information

Authors and Affiliations

Authors

Contributions

EVW, MAC and EDS were involved in study concept and design. PMC performed statistical analysis. EVW authored the initial draft of the manuscript. EDS supervised the conduct of this study. All authors critically revised the manuscript and approved the final copy.

Corresponding author

Correspondence to Eric D. Shah.

Ethics declarations

Competing interests

Dr. Shah has consulted for GI Supply, Ardelyx, Bausch Health, Mylan, Salix, Sanofi, Takeda, and Mahana. The other authors have no disclosures.

Ethical approval

The Institutional Review Board at Dartmouth-Hitchcock determined that this study was exempt from review, prior to initiation of our study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wechsler, E.V., Martinez-Camblor, P., Curley, M.A. et al. Chronic Pain and Mood Disorders Are Not Barriers to Symptom Improvement Under Collaborative Co-managed Care (C3). Dig Dis Sci 68, 3569–3572 (2023). https://doi.org/10.1007/s10620-023-08055-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-023-08055-4

Keywords

Navigation